论文部分内容阅读
本文对40例肺心病心衰患者随机分成甲、乙两组,依据不同的临床治疗进行比较分析,治疗结果经统计学处理,两组之间差异显著,指出了扩血管药物硝苯吡啶在心衰治疗上的重要性。现报告如下。 1 临床资料 本院2年来共收治肺心病心衰患者40例,男28例,女12例。肺心病26例,肺心病合并冠心病14例。年龄最大76岁,最小56岁,平均66岁。临床症状,均有胸闷、气喘、呼吸困难,腹胀,尿少。除心脏体征外,均有颈静脉怒张,肺部湿性罗音,肝肿大,下肢
In this paper, 40 cases of heart failure patients with cor pulmonale were randomly divided into A and B groups, according to different clinical treatment were compared and analyzed, the treatment results were statistically significant differences between the two groups, pointed out that the vasodilator drug nifedipine in the heart The importance of bad treatment. The report is as follows. 1 Clinical data Hospital in the past two years, 40 cases of heart failure patients with pulmonary heart disease, 28 males and 12 females. Pulmonary heart disease in 26 cases, cor pulmonale with coronary heart disease in 14 cases. The oldest 76 years old, the youngest 56 years old, average 66 years old. Clinical symptoms, both chest tightness, asthma, dyspnea, bloating, oliguria. In addition to heart signs, there are jugular venous distention, lung wet rales, hepatomegaly, lower extremities